[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:kshv":3},{"name":4,"total":5,"recruiting":5,"trials":6},"KSHV",5,[7,15,21,27,33],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT01419561","Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)",[11],"Phase 2","RECRUITING","2026-08-26T02:17:54.420226Z","2026-05-05T02:43:27.832640Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06052618","Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)",[11],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:27.493473Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT05907759","Daratumumab for Relapsed\u002FRefractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease",[11],"2026-08-26T02:18:43.501109Z","2026-05-05T02:43:26.949844Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT04968288","Natural History of KSHV-Associated Multicentric Castleman s Disease",[],"2026-08-26T02:19:07.104270Z","2026-05-13T02:55:06.275783Z",{"nct_id":34,"title":35,"phases":36,"status":12,"updated_at":37,"content_modified":38},"NCT00006518","Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer",[],"2026-08-26T02:17:21.315591Z","2026-05-13T02:55:06.028653Z"]